Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . May 5th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
DNA Vaccine - Transdermal gene delivery eradicates tumors expressing hepatitis C proteins
Radiology - Magnetic resonance spectroscopy could replace the use of HCV-related biopsy
Adoptive Immunotherapy - Roadblocks to tumor vaccines could be overcome with interleukin-2
Hepatitis C Therapy - The choice to continue therapy for chronic hepatitis C can be made in 12 weeks
Virology - Core-envelope 1-based assays can quickly distinguish hepatitis C virus subtypes
Virology - The Hungarian population is host to several different TT virus genotypes
Chronic Hepatitis C - Soluble ICAM-I correlates with response to retreatment for hepatitis C virus
Cirrhosis - Helicobacter pylori infection may affect cytochrome-linked liver activity
Environmental Health - RNA analysis enables the detection of hepatitis A virus in oysters
Epidemiology - Knowledge of factors behind hepatitis C virus in veterans improves screening
HCV Treatment - Positive hepatitis C, hepatitis B treatment results released
Hematology - Hepatitis C virus RNA stability in plasma relies on storage temperatures
Hepatitis B Vaccine - Cytokine polymorphisms modulate UVB-induced immune responses to HBV vaccine
Hepatitis B Virus - Pegasys doubles the efficacy in CHB versus conventional interferon
Hepatitis C Diagnosis - Nested PCR assay validated for the detection of hepatitis C virus
Hepatitis C Proteomics - Inhibitor-binding site location interferes with hepatitis C virus polymerase
Hepatitis C Therapy - Hemoglobinuria may be an adverse effect of ribavirin treatment
Hepatitis C Vaccine - CpG enhances antibody response against hepatitis C virus core protein
Hepatitis C Virus - FDA grants priority review to Rebetol
Hepatitis C Virus - New research establishes genetic associations
Hepatology - Antisense oligonucleotides against aldehyde dehydrogenase suppress liver cancer
Hepatology - NS-398 defeats liver cancer by inhibiting COX-2
Infectious Disease Testing - FDA licenses granted for new hepatitis B tests
Infectious Disease Testing - Hepatitis B assay released
Liver Cancer - Hepatitis B and C viruses generate differential apoptosis signals
Oncogenesis - Hepatitis infections may disable repair genes by promoter hypermethylation
Psychology - Optimism or pessimism relate to quality-of-life issues for hepatitis patients
Viral Genomics - The nuclear orphan receptor TR4 suppresses hepatitis B virus core promoter
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
